Canara Robeco AMC shares were issued today at an IPO price of ₹266 and listed on the market at ₹280.25. Subsequently, the shares reached ₹291.50, providing investors with a profit of up to 9.59%. The company's financial health is b, with net profit and total income consistently increasing over the past three years.
Canara Robeco AMC IPO Listing: Shares of Canara Robeco Asset Management Company (AMC) were listed on the domestic stock market today. The shares were issued at ₹266 under the IPO, and today they debuted on both BSE and NSE at ₹280.25. Following the listing, the shares gained momentum, reaching ₹291.50, which resulted in a profit of up to 9.59% for investors. The company's IPO was an Offer For Sale, and it received a good response from investors. Financially, the company is b, with its net profit increasing from ₹79 crore to ₹190.70 crore and total income reaching ₹404 crore over the past three years.
IPO Response
Canara Robeco AMC's ₹1,326 crore IPO was open from October 9 to 13 and received a b response from investors. The IPO was subscribed 9.74 times overall. The portion reserved for Qualified Institutional Buyers (QIBs) was subscribed 25.92 times, for Non-Institutional Investors (NIIs) 6.45 times, and for retail investors 1.91 times.
No new shares were issued under this IPO, and all shares were sold by the promoters through an Offer For Sale (OFS). Canara Bank and ORIX Corporation Europe sold stakes totaling 49,854,357 shares, each with a face value of ₹10. Canara Bank sold 25,924,266 shares, and ORIX Corporation Europe sold 23,930,091 shares. Since it was an Offer For Sale, the company did not receive any proceeds from the IPO.
Company Business Information
Canara Robeco AMC was established in 1993. It provides investment management services for Canara Robeco Mutual Fund. Its headquarters are in Mumbai, and it operates as a joint venture between Canara Bank and ORIX Corporation Europe N.V. The company offers various investment options, including equity, debt, and hybrid schemes. As of June 2025, the company was managing 26 schemes, comprising 15 equity-oriented schemes, 3 hybrid schemes, and 11 debt-oriented schemes.
Financial Health
The company's financial health appears robust. In FY2023, the company's net profit was ₹79.00 crore, which increased to ₹151.00 crore in FY2024 and ₹190.70 crore in FY2025. During this period, total income grew at a compound annual growth rate of over 40 percent, reaching ₹404.00 crore.
In the first quarter of FY2026 (April-June 2025), the company achieved a net profit of ₹60.98 crore and a total income of ₹121.34 crore. The company's debt stood at ₹278.70 crore at the end of FY2023, rising to ₹404.64 crore in FY2024 and ₹400.64 crore in FY2025. In the June quarter of FY2026, it reached ₹461.19 crore.
Meanwhile, the reserves and surplus position has also strengthened. Reserves stood at ₹328.55 crore at the end of FY2023, increasing to ₹454.49 crore in FY2024 and ₹600.06 crore in FY2025. In the June 2025 quarter, reserves and surplus reached ₹660.60 crore.
Benefits for Investors
On the very first day of listing, the shares showed a premium performance. IPO investors received a listing gain of over 5 percent, and the share price reached ₹291.50. This performance boosted investor confidence and also demonstrated the company's financial strength.
